Subclinical Vascular Damage: Current Insights and Future Potential.


Journal

Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479

Informations de publication

Date de publication:
2021
Historique:
received: 03 09 2021
accepted: 13 11 2021
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

The cardiovascular risk assessment must be carried out during all the different phases of life because the cardiovascular risk and the related prevention actions are dynamic and constantly evolving. As patients age, they change their exposure to various risk factors and accumulate comorbidities by changing their subjective cardiovascular risk, so it is necessary to undertake personalized early and preventive diagnostic actions. The main approach to asymptomatic vascular disease is based on primary prevention with the adoption of a healthy lifestyle. Indeed, lifestyle influences most of the traditional risk factors. In recent years, important differences between the sexes regarding cardiovascular risk factors have emerged and in particular, risk factors specific for female sex have been identified. Women are more likely to be categorized into lower risk categories for cardiovascular disease and, as a result, receive less lifestyle counseling than men, as well as less intensive prevention. This narrative review aims to analyze CVD risk prevention in asymptomatic atherosclerosis with a look at new emerging factors. In the end, we quickly analyzed the effects of the recent pandemic on lifestyle and cardiovascular risk and the potential negative effects in the long term.

Identifiants

pubmed: 34866906
doi: 10.2147/VHRM.S242636
pii: 242636
pmc: PMC8633547
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-738

Informations de copyright

© 2021 Mattioli et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Am Heart Assoc. 2019 Jun 4;8(11):e012638
pubmed: 31140334
Circ J. 2021 Jul 21;85(8):1365-1372
pubmed: 33597325
Front Endocrinol (Lausanne). 2015 Apr 24;6:55
pubmed: 25964776
Exp Cell Res. 2019 Jun 15;379(2):191-202
pubmed: 30970236
Arch Intern Med. 2007 Jan 8;167(1):31-9
pubmed: 17210875
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Nutr Res Rev. 2008 Dec;21(2):117-33
pubmed: 19087366
Circulation. 2012 May 15;125(19):2363-73
pubmed: 22586291
Am J Lifestyle Med. 2020 Dec 10;15(3):356-359
pubmed: 34025328
Future Cardiol. 2021 May;17(3):487-496
pubmed: 33739145
Cell. 2012 Mar 16;148(6):1258-70
pubmed: 22424233
Mol Cell Neurosci. 2020 Oct;108:103538
pubmed: 32828963
Viruses. 2021 Apr 18;13(4):
pubmed: 33919537
JAMA. 2009 Aug 26;302(8):874-82
pubmed: 19706861
Nutrients. 2020 Mar 23;12(3):
pubmed: 32209978
Nat Rev Endocrinol. 2021 Jan;17(1):47-66
pubmed: 33173188
Rev Cardiovasc Med. 2019 Sep 30;20(3):121-128
pubmed: 31601086
Basic Res Cardiol. 2020 Jun 6;115(4):41
pubmed: 32506214
Physiol Genomics. 2018 Apr 1;50(4):244-254
pubmed: 29373083
Nutr Rev. 2006 Jan;64(1):47-50
pubmed: 16491670
Front Cell Infect Microbiol. 2020 Oct 23;10:530160
pubmed: 33194785
J Am Coll Cardiol. 1994 Nov 15;24(6):1468-74
pubmed: 7930277
Int J Environ Res Public Health. 2019 Apr 01;16(7):
pubmed: 30939754
Eur Heart J. 2004 Apr;25(8):663-70
pubmed: 15084371
Adv Nutr. 2020 Jul 1;11(4):815-833
pubmed: 32059053
Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25
pubmed: 27461391
Eur J Prev Cardiol. 2019 Apr;26(6):609-610
pubmed: 30373379
Palliat Support Care. 2020 Aug;18(4):394-399
pubmed: 32594950
Eur J Prev Cardiol. 2021 May 8;28(4):361-369
pubmed: 33611390
Curr Cardiol Rep. 2021 Aug 19;23(10):143
pubmed: 34410533
Obes Med. 2020 Dec;20:100263
pubmed: 32838051
Nature. 2002 Jun 13;417(6890):750-4
pubmed: 12066187
Nutr Metab Cardiovasc Dis. 2017 Nov;27(11):985-990
pubmed: 29074382
Curr Atheroscler Rep. 2021 Sep 1;23(11):71
pubmed: 34468868
Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):63-70
pubmed: 27833015
Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40
pubmed: 20577089
Eur Heart J. 2008 Jun;29(11):1359-69
pubmed: 18424787
J Am Coll Cardiol. 2021 Aug 3;78(5):513-531
pubmed: 34325840
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458
pubmed: 33554620
J Phys Act Health. 2010 Nov;7 Suppl 3:S370-85
pubmed: 21116016
Vascul Pharmacol. 2015 Aug;71:40-56
pubmed: 25869516
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
PLoS One. 2020 Aug 13;15(8):e0236951
pubmed: 32790754
Front Cell Dev Biol. 2021 Jul 07;9:673839
pubmed: 34307357
Oncotarget. 2017 Aug 18;8(44):77020-77027
pubmed: 29100366
Circulation. 2004 Feb 10;109(5):613-9
pubmed: 14769683
Nutrients. 2021 Apr 30;13(5):
pubmed: 33946280
J Am Coll Cardiol. 2019 Sep 24;74(12):1608-1617
pubmed: 31537271
Crit Rev Food Sci Nutr. 2018;58(18):3070-3084
pubmed: 29039967
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1569-H1588
pubmed: 30216121
J Cardiovasc Med (Hagerstown). 2018 Apr;19(4):183-185
pubmed: 29489740
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73
pubmed: 20082925
Front Cell Dev Biol. 2020 Sep 22;8:586189
pubmed: 33072766
Eur Heart J. 2008 May;29(9):1198-206
pubmed: 18079136
Eur Heart J. 2021 Jan 1;42(1):6-7
pubmed: 33180902
Circ Res. 2016 Apr 15;118(8):1273-93
pubmed: 27081110
Nutrients. 2021 Jun 10;13(6):
pubmed: 34200879
Clin Cardiol. 2019 Jan;42(1):39-46
pubmed: 30318598
Trends Cardiovasc Med. 2022 Jan;32(1):12-17
pubmed: 34619336
Clin Chim Acta. 2017 Aug;471:185-190
pubmed: 28606604
Front Cardiovasc Med. 2020 Feb 25;7:22
pubmed: 32158768
Trends Cardiovasc Med. 2022 May;32(4):181-194
pubmed: 33872757
Future Cardiol. 2020 Nov;16(6):539-542
pubmed: 32351128
Nature. 2013 Aug 29;500(7464):541-6
pubmed: 23985870
Biogerontology. 2019 Oct;20(5):605-626
pubmed: 31309340
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2813-20
pubmed: 23152494
Front Pharmacol. 2020 Jan 31;10:1606
pubmed: 32082147
Circ Res. 2019 Jun 7;124(12):1808-1820
pubmed: 30971183
J Am Coll Cardiol. 2009 May 26;53(21):1925-32
pubmed: 19460605
Nature. 2013 Aug 29;500(7464):585-8
pubmed: 23985875
J Cardiovasc Med (Hagerstown). 2019 Sep;20(9):575-583
pubmed: 31246698
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Eur J Endocrinol. 2008 Feb;158(2):179-87
pubmed: 18230824
Nat Commun. 2017 Oct 10;8(1):845
pubmed: 29018189
Circ Cardiovasc Imaging. 2020 Aug;13(8):e011054
pubmed: 32762255
Am Heart J. 2020 Jun;224:113-128
pubmed: 32361531
J Cardiovasc Med (Hagerstown). 2019 Oct;20(10):631-639
pubmed: 31436678
Br J Gen Pract. 2011 Mar;61(584):e125-33
pubmed: 21375895
Cardiovasc Res. 2011 Dec 1;92(3):367-74
pubmed: 21764886

Auteurs

Anna Vittoria Mattioli (AV)

Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Francesca Coppi (F)

Cardiology Division, Policlinico di Modena, Modena, Italy.

Antonio Manenti (A)

Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Alberto Farinetti (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH